At the news
? NEUTRALIMPACT 4/10 8-K filed Jun 29, 2026 at 09:00 ET
Macerich reports that underwriters exercised their option in full to purchase an additional 2.1 million shares of common stock at $23.12325 per share as part of a forward sale agreement, bringing total potential shares offered to 16.1 million. The proceeds will be used for acquisitions and general corporate purposes. This is a procedural update following the initial offering disclosure on June 15, 2026.
- Underwriters exercised option for 2,100,000 shares at $23.12325 per share on June 23, 2026.
- Option closing occurred on June 26, 2026.
- Company expects to physically settle forward agreements by June 16, 2027; may alternatively cash or net share settle.
- Net proceeds will be contributed to the Operating Partnership for acquisitions and general corporate purposes.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access